Search company, investor...
BoneSupport company logo


Founded Year




Total Raised


Date of IPO


About BoneSupport

BoneSupport specializes in injectable bone graft substitutes for orthopedic trauma focusing on bone infection, instrument augmentation and spinal applications. CERAMENT is an injectable, synthetic bone substitute that mimics the properties of cancellous bone, allows for controlled resorption to support future bone ingrowth and is injectable under local anesthesia for minimally invasive surgery. CERAMENT's unique biologic properties deliver a consistent, pre-packed and ready-to-use formulation to facilitate optimal delivery. CERAMENT|G is the first CE-marked injectable gentamicin antibiotic eluting ceramic bone graft substitute. CERAMENT|G is indicated to promote and protect bone healing in the management of osteomyelitis, (bone infections) in CE marked countries.

Headquarters Location

Scheelevagen 19A

Lund, SE-223 70,


+46 46 286 53 70

Missing: BoneSupport's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BoneSupport's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BoneSupport

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BoneSupport is included in 3 Expert Collections, including Advanced Materials.


Advanced Materials

1,282 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.


Medical Devices

11,918 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Latest BoneSupport News

Bonesupport : Financials

Apr 27, 2023

Bonesupport : Financials Message : KPI's 4,6 0,3 272,2 -174,0 190,4 0,00 23 255 7 884 -8 626 -436 -1 798 -10 860 201 281 190 399 -61 025 Q1 2023 -26 106 -562 -88 043 -174 869 The Group's segments are North America (NA) and Europe & Rest of the World (EUROW). Other comprises other items, mainly costs for Group functions. Contribution per segment is calculated as net sales minus costs that are directly attributable operating costs. Such costs are related to cost of sales, selling expenses including commissions and fees and research and development expenses. Assets and liabilities are not reported by segment, these are managed and monitored on Group level by management and the Board of directors. Attachments

BoneSupport Frequently Asked Questions (FAQ)

  • When was BoneSupport founded?

    BoneSupport was founded in 1999.

  • Where is BoneSupport's headquarters?

    BoneSupport's headquarters is located at Scheelevagen 19A, Lund.

  • What is BoneSupport's latest funding round?

    BoneSupport's latest funding round is IPO.

  • How much did BoneSupport raise?

    BoneSupport raised a total of $79.98M.

  • Who are the investors of BoneSupport?

    Investors of BoneSupport include HealthCap Venture Capital, Industrifonden, Lundbeckfond Ventures, AP3, Kreos Capital and 9 more.

  • Who are BoneSupport's competitors?

    Competitors of BoneSupport include RxSight, Cagenix, BAROnova, Elute, SpineForm and 12 more.

Compare BoneSupport to Competitors


SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.

Minimus Spine Logo
Minimus Spine

Minimus Spine is developing ozone injection technology specifically for spinal applications. The company has improved upon the existing technology through a system that creates ozone, and measures its concentration, within in a sterile, syringe-cartridge. This has advantages in terms of sterility and dose assurance, as well as material compatibility, which are vital to the advancement of this technique.


Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. It offers balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. The company was founded in 1994 and is based in Sunnyvale, California.

Proneuron Biotechnologies

Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.

NeoChord Logo

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.

TransCorp Logo

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.